Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy
| dc.contributor.author | Kathuria, Sushruta | en_US |
| dc.contributor.author | Gautam, Yugansh | en_US |
| dc.contributor.author | Khunger, Niti | en_US |
| dc.contributor.author | Sharma, Shruti | en_US |
| dc.contributor.author | Singh, Ruchi | en_US |
| dc.date.accessioned | 2025-08-13T09:35:52Z | |
| dc.date.available | 2025-08-13T09:35:52Z | |
| dc.date.issued | 2025-06 | |
| dc.description.abstract | In the current scenario, treatment of Post kala-azar dermal leishmaniasis (PKDL) is intravenous liposomal amphotericin B or oral miltefosine. Over the years, there has been a gradual decline in the efficacy of miltefosine and a rise in permanent loss of vision. Moreover, in non-endemic states of India, miltefosine is not freely available. In view of this, we attempted a two-step regimen of liposomal amphotericin B and itraconazole to treat two patients of PKDL diagnosed on histopathology as well as PCR. We found this treatment to be highly effective with complete recovery. | en_US |
| dc.identifier.affiliations | Department of Dermatology and Venerology, Safdarjung Hospital and V Vardhaman Mahavir Medical College, New Delhi, India | en_US |
| dc.identifier.affiliations | Department of Dermatology and Venerology, Safdarjung Hospital and V Vardhaman Mahavir Medical College, New Delhi, India | en_US |
| dc.identifier.affiliations | Department of Dermatology and Venerology, Safdarjung Hospital and V Vardhaman Mahavir Medical College, New Delhi, India | en_US |
| dc.identifier.affiliations | ICMR- National Institute of Pathology, New Delhi, India | en_US |
| dc.identifier.affiliations | ICMR- National Institute of Pathology, New Delhi, India | en_US |
| dc.identifier.citation | Kathuria Sushruta, Gautam Yugansh, Khunger Niti, Sharma Shruti, Singh Ruchi. Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy. Journal of Vector Borne Diseases . 2025 Jun; 62(2): 248-251 | en_US |
| dc.identifier.issn | 0972-9062 | |
| dc.identifier.place | India | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/252562 | |
| dc.language | en | en_US |
| dc.publisher | Wolters Kluwer – Medknow | en_US |
| dc.relation.issuenumber | 2 | en_US |
| dc.relation.volume | 62 | en_US |
| dc.source.uri | https://doi.org/10.4103/JVBD.JVBD_205_24https://creativecommons.org/licenses/by-nc-sa/4.0 | en_US |
| dc.subject | post kala azar dermal leishmaniasis | en_US |
| dc.subject | itraconazole | en_US |
| dc.subject | amphotericin B | en_US |
| dc.title | Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy | en_US |
| dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- JVBD2025v62n2p248.pdf
- Size:
- 1.39 MB
- Format:
- Adobe Portable Document Format